Related Experiment Video
Updated: Jun 6, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
94
Classifying cognitive impairment based on FDG-PET and combined T1-MRI and rs-fMRI: An ADNI study
Iman Jahani1, Ali Jahani1, Mehdi Delrobaei1,2
1Department of Biomedical Engineering, Faculty of Electrical Engineering, K. N. Toosi University of Technology, Tehran, Iran.
Journal of Alzheimer'S Disease : JAD
|December 3, 2024
Summary
Fluorodeoxyglucose positron emission tomography (FDG-PET) effectively classifies mild cognitive impairment (MCI) versus cognitively normal (CN) adults. While MRI showed lower accuracy, it remains valuable for neurodegeneration assessment.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Neurology
Background:
- Mild cognitive impairment (MCI) is a precursor to dementia, necessitating advanced diagnostic tools.
- Heterogeneity of MCI requires novel approaches for accurate classification and prediction.
- Fluorodeoxyglucose positron emission tomography (FDG-PET) offers robust Alzheimer's disease (AD) biomarkers.
Purpose of the Study:
- To classify individuals with MCI versus cognitively normal (CN) adults using FDG-PET.
- To predict MCI individuals who will convert to AD dementia.
- To compare the diagnostic performance of MRI against FDG-PET for MCI classification.
Main Methods:
- A 3D DenseNet deep learning model was trained on FDG-PET images from 805 participants (MCI/CN).
- MRI and functional MRI data from 348 participants were used to train alternative classification models.
- Performance was evaluated using 10-fold cross-validation across four ADNI cohorts.
Main Results:
- The FDG-PET model achieved 88.02% accuracy in classifying MCI vs. CN.
- MRI-based models yielded lower accuracy, with the highest reaching 76.86%.
- The FDG-PET model showed 63.23% accuracy in predicting MCI converters versus stable MCI.
Conclusions:
- FDG-PET imaging demonstrates superior accuracy for classifying MCI versus CN.
- Although less accurate than FDG-PET, multi-contrast MRI provides valuable insights for neurodegeneration classification.
- Deep learning models show promise for analyzing neuroimaging data in MCI and AD research.
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
